Gene · 1
Papers2,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacological characterization of the α2A-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency. | J Recept Signal Transduct Res | 2022 | 35984443 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC. | Genet Res (Camb) | 2022 | 35975176 | PubTator, text mining | PubMed |
| Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes. | Front Immunol | 2022 | 35967388 | PubTator, text mining | PubMed |
| Phaseolus vulgaris Erythroagglutinin (PHA-E)-Positive Ceruloplasmin Acts as a Potential Biomarker in Pancreatic Cancer Diagnosis. | Cells | 2022 | 35954297 | PubTator, text mining | PubMed |
| Immunological Tolerance in Liver Transplant Recipients: Putative Involvement of Neuroendocrine-Immune Interactions. | Cells | 2022 | 35954171 | PubTator, text mining | PubMed |
| Serum Ceruloplasmin as a Potential Clinical Biomarker in Atopic Dermatitis. | Ann Dermatol | 2022 | 35948326 | PubTator, text mining | PubMed |
| Hemoglobin Wayne: A Rare Variant That Can Cause Falsely Elevated Hemoglobin A1c. | Cureus | 2022 | 35936177 | PubTator, text mining | PubMed |
| Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study. | Lancet Planet Health | 2022 | 35932787 | PubTator, text mining | PubMed |
| A multiomics disease progression signature of low-risk ccRCC. | Sci Rep | 2022 | 35931808 | PubTator, text mining | PubMed |
| Thirty Years of Mungbean Genome Research: Where Do We Stand and What Have We Learned? | Front Plant Sci | 2022 | 35909762 | PubTator, text mining | PubMed |
| NMR-based isotope editing, chemoselection and isotopomer distribution analysis in stable isotope resolved metabolomics. | Methods | 2022 | 35908585 | PubTator, text mining | PubMed |
| Last but not least: BFL-1 as an emerging target for anti-cancer therapies. | Biochem Soc Trans | 2022 | 35900226 | PubTator, text mining | PubMed |
| Do adrenergic alpha-antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta-analysis. | ESC Heart Fail | 2022 | 35894772 | PubTator, text mining | PubMed |
| Validation of Serotransferrin in the Serum as Candidate Biomarkers for the Diagnosis of Pulmonary Tuberculosis by Label-Free LC/MS. | ACS Omega | 2022 | 35874208 | PubTator, text mining | PubMed |
| Concentration of Serum Biomarkers of Brain Injury in Neonates With a Low Cord pH With or Without Mild Hypoxic-Ischemic Encephalopathy. | Front Neurol | 2022 | 35873777 | PubTator, text mining | PubMed |
| Valence-controlled protein conjugation on nanoparticles via re-arrangeable multivalent interactions of tandem repeat protein chains. | Chem Sci | 2022 | 35872829 | PubTator, text mining | PubMed |
| Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrhosis. | Toxicol Res | 2022 | 35865277 | PubTator, text mining | PubMed |
| Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX). | Pharmacoecon Open | 2022 | 35861912 | PubTator, text mining | PubMed |
| G Protein-Coupled Receptors-Receptors With New Tricks Up Their Sleeves. | J Cardiovasc Pharmacol | 2022 | 35853195 | PubTator, text mining | PubMed |
| Identification of novel biomarkers and therapeutic target candidates for stasis-heat symptom pattern of acute intracerebral hemorrhage by quantitative plasma proteomics. | J Tradit Chin Med | 2022 | 35848980 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1/papers?page=20